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Abstract 
Background. Increased arterial stiffness and sympathetic nervous system activity, 
independent markers of cardiovascular risk, are common in patients with severe obstructive 
sleep apnoea, who have excessive daytime sleepiness. Amongst patients with mild-to-
moderate obstructive sleep apnoea, however, it remains unknown whether arterial stiffness 
and/or increased sympathetic nervous system activity correlate with excessive daytime 
sleepiness.   
Methods. We measured heart rate variability, as an index of autonomic nervous system 
activity, and arterial stiffness index, as a marker of vascular damage and cardiovascular risk, 
in 56 men aged 18 to 75 years, with mild-to-moderate obstructive sleep apnoea, and matched 
into two groups, “sleepy” (Epworth Sleepiness Scale≥10) and “non-sleepy” (Epworth 
Sleepiness Scale<10).  
Results. We found no association of excessive daytime sleepiness with sympathetic nervous 
system activation (very low frequency power 18,947 ± 11,207 ms2 vs 15,893 ± 8,272 ms2, 
p=0.28; low frequency (LH) power 17,753 ± 8,441 ms2 vs 15,414 ± 5,666 ms2, p=0.26; high 
frequency (HF) power 7,527 ± 1,979 ms2 vs 8,257 ± 3,416 ms2, p=0.36; LF/HF ratio 3.04 ± 
1.37 vs 2.55 ± 1.01, p=0.15) and arterial stiffness index ( 83 vs 
in mild-to-moderate obstructive sleep apnoea patients, with and without excessive daytime 
sleepiness, respectively.  
Conclusions. Symptoms of excessive daytime sleepiness seem to not correlate with 
sympathetic nervous system activation and arterial stiffness in mild-to-moderate obstructive 
sleep apnoea patients.   
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1. Introduction  
Obstructive sleep apnoea (OSA) represents an independent risk factor for cardiovascular 
(CV) diseases; it causes recurrent episodes of upper airway collapse during sleep, resulting in 
apnoeas and hypopnoeas, blood oxygen desaturation, and arousal from sleep [1].  The 
ensuing sleep fragmentation, excessive daytime sleepiness (EDS), and alterations of 
autonomic activity at night, which can persist during the day [2], lead to impaired quality of 
life and reduce the overall chances of CV-events free survival.  The autonomic nervous 
system (ANS) is affected by sleep-disordered breathing with a shift of the sympatho-vagal 
balance towards a sympathetic predominance and a reduced vagal tone [3].  Arterial stiffness, 
which estimates the reduced capacity of arteries to expand and contract in response to 
pressure changes, is known to increase mainly in relation to ageing and atherosclerosis, and 
represents an independent CV risk factor [4]. It was found to be increased in patients with 
severe OSA, when measured by pulse wave velocity [5] and it has been showed significant 
improvements in all indices of arterial stiffness after continuous positive airway pressure 
(CPAP) treatment [6]. Recently, the photo-plethysmography-derived digital volume pulse 
(DVP) has been developed to quantify arterial stiffness easily and non-invasively, allowing 
calculation of the stiffness index (SIDVP) that reflects systemic arterial stiffness [7].   
Increased sympathetic tone and arterial stiffening are both common in patients with severe 
OSA [8-9], but whether this applies to mild-to-moderate OSA patients and whether EDS 
correlates with an increase in sympathetic drive and arterial stiffness remains uncertain.  
Thus, our aims were to determine: i) if patients with mild-to-moderate OSA have detectable 
signs of increased sympathetic nervous system (SNS) activity and arterial stiffness; ii) if EDS 
correlates with markers of CV risk.  
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2. Methods 
After prospectively screening 458 patients newly referred to our Sleep Centre, we collected 
data from 56 normotensive males aged between 18 and 75 years, with no known CV risk 
factors, no comorbidities associated with autonomic failure, such as diabetes mellitus and 
Shy-Drager syndrome, or any other chronic sleep disorders, who had an apnoea-hypopnoea 
index (AHI) ≥5 and <30 events per hour during nocturnal polysomnography recording 
(NPSG) (Embla®N7000, USA).  All patients were assessed with the Epworth Sleepiness 
Scale (ESS) [10]. Patients on medication affecting HRV and those previously treated with 
CPAP or with mandibular advance devices were excluded.  Respiratory pattern was analysed 
in accordance with American Academy of Sleep Medicine criteria [11].  The SIDVP was 
measured by photo-plethysmography of the right index finger, generated from the pulse-
oximeter trace of the recorded NPSGs, during 2 minutes in the wake stage, prior to sleep 
onset, and in the morning, after completion of the study, while the patient lay relaxed without 
external stimuli.  Heart rate parameters were derived from the NPSG electrocardiogram 
recording during the same two periods used for the analysis of arterial stiffness, and during 
the whole night of the study, and analysed by the Embla®RemLogic™PSG Software. 
Frequency-domain indices were calculated, as equivalent to time-domain values [12].  
2.1 Power and sample size calculation 
We estimated the difference in means between very low frequency power in patients with and 
without EDS as 944±839 vs 447±461 msec2, using data from a previous study on HRV in 
patients with OSA [13], and measured a common standard deviation (SD) considered as 
mean of the two SD.  We calculated (using nQueryTM, Vers.7.0) that a two group unequal 
number t-test with a 0.05 two-sided significance level has 80% power to detect the 
2, assuming that the 
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common standard deviation was 650,000, when the sample sizes in the two groups are 30 and 
25, respectively. 
2.2 Statistical analysis 
“Non-sleepy” (ESS<10) and “sleepy” (ESS≥10) patients were compared using the 
independent samples t-test and non-normally distributed data by non-parametric Mann-
Witney test.  After co-linearity issues were preliminarily excluded by formal testing, linear 
regression analysis (backward, Wald) was used to identify predictors of HRV and SIDVP.  As 
in this type of observational study an unbalanced distribution of potentially confounding co-
variates between normal and elevated ESS groups is likely, propensity score matching was 
also undertaken using the identified predictors [14].  A p<0.05 was considered to be 
statistically significant.  Statistical analysis was performed using the SPSS statistical analysis 
programme (SPSS 23.0 for Mac, SPSS-IBM, Bologna, Italy).  
 
3. Results 
Of the 56 recruited patients, 31 had an ESS>10 and 25 an ESS≤10.  The two groups did not 
differ significantly for baseline data (Table 1) neither for the stiffness index and HRV 
indices.  Regression analysis allowed identification of age, AHI, and ODI as independent 
predictors of arterial stiffness: a model with these variables predicted about 12% of SIDVP 
variance (F=3.49; p=0.022, Adjusted R2=0.120).  As regards to HRV, a regression model 
with the same variables predicted about 11% of HRV variance (F=7.509; p=0.008, Adjusted 
R2=0.106).   Thus, these variables were used for the propensity score matching.  After this, 25 
cases and 25 controls could be matched and were further compared in terms of HRV (very 
low frequency power 18,947 ± 11,207 ms2 vs 15,893 ± 8,272 ms2, p=0.28; low frequency 
(LH) power 17,753 ± 8,441 ms2 vs 15,414 ± 5,666 ms2, p=0.26; high frequency (HF) power 
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7,527 ± 1,979 ms2 vs 8,257 ± 3,416 ms2, p=0.36; LF/HF ratio 3.04 ± 1.37 vs 2.55 ± 1.01, 
p=0.15) and mean SIDVP vs 
significant differences between the groups with and without EDS for these endpoints (Figure 
1). 
 
4. Discussion  
The results of this proof-of-principle study showed that validated indices of SNS activation 
and arterial stiffening did not differ between the groups according to the presence or absence 
of EDS in patients with mild-to-moderate OSA.  These results complement those of a recent 
prospective study, which showed that although sleepy patients are more likely to have more 
severe OSA, tend to be more hypertensive, and to have uncontrolled blood pressure (BP), 
they do not have any features of increased arterial stiffness and CV risk than non-sleepy 
patients [15]. 
This is of interest in that current guidelines recommend CPAP therapy for patients with mild-
to-moderate OSA if they exhibit symptoms of EDS [16, 17].  It has already been established 
that not all patients with OSA benefit from CPAP and a beneficial effect of CPAP on BP 
control.  It has been demonstrated that patients with OSA who suffer from EDS have a higher 
rate of hypertension and a higher CV risk compared with those without EDS [18], and that 
CPAP therapy is less effective in improving BP and preventing the occurrence of 
hypertension in OSA patients without EDS [19]. Furthermore, Robinson and colleagues 
reported that in “non-sleepy” OSA patients there was no significant BP reduction, suggesting 
that there is no clear benefit from treating patients with OSA without EDS using CPAP [20]. 
These reports, although used self-reported sleepiness was assessed using the ESS, suggest 
that subjective EDS is associated with hypertension and CV risk in OSA, and that patients 
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with severe disease are more likely to be symptomatic and seem to respond better to 
treatment than patients without EDS.  
These findings could have important implications: currently, sleep studies, including full 
NPSG, are unfeasible in the large cohorts of patients who might be considered to require 
them.  This means that a strategy for prior (pre-test) patients stratification for likelihood of 
OSA and associated CV risk is necessary to select which patients to test.  Questionnaires, as 
the ESS, are already used for this purpose.  Therefore, it is an important finding that our study 
failed to identify any significant relationship between EDS and two surrogate markers for CV 
risk, SNS activity and arterial stiffness. Based on these findings, a reliable identification of 
the patients with higher CV risk among those with mild-to-moderate OSA cannot be 
determined by the use of the ESS.   
 
Limitations 
This was a proof-of-principle study with has several limitations and strengths, including the 
careful selection of patients, the undertaking of a polysomnography, the statistical power 
calculation, and the stratification for overall risk by means of state-of-the art criteria.  
However, the cross-sectional design and the small sample size were exploited in order to 
minimize confounders.  Moreover, as we selected normotensive patients, there was a lack of 
BP measurements in supine and upright posture.  Likewise, the duration of OSA, which could 
potentially influence both SNS activation and arterial stiffening, was not measured. Lastly, 
our study was underpowered to address the hypothesis that REM-related-OSA is associated 
with BP changes, arterial stiffness and HRV. It might also be argued that our negative results 
concerning the lack of association between validated indices of SNS activation and of large 
arteries stiffness and in mild-to-moderate OSA patients might be explained by multiple other 
variables that are theoretically capable of influencing the study endpoints.  However, firstly, 
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our groups were well matched and, secondly, with the use of propensity score matching we 
adjusted for the unbalanced distribution of co-variates controlling for unknown potential 
confounders.  
 
5. Conclusions  
This proof-of-principle study provides evidence that EDS do not correlate with SNS 
activation and arterial stiffness in patients with mild-to-moderate OSA.   
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Caption 
Figure 1. Frequency domain variables in patients with Epworth Sleepiness Scale ≥10 
compared with “non-sleepy” patients (ESS<10). Panel A: very low frequency power 
(VLF); B: low frequency power (LF); C: high frequency power (HF); D: LF/HF ratio. 
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Table 1. Baseline and polysomnography data of the two subgroups.   
 ESS > 10 
(n = 31) 
ESS ≤ 10 
(n = 25) 
p value 
Age (years) 44.1 (10.6) 45.8 (9.5) 0.53 
Body Mass Index (kg/m2) 29.3 (6.1) 29.3 (4.8) 1 
Epworth Sleepiness Scale 
(ESS) 
15.6 (3.0) 6.6 (2.7) < 0.001 
Apnoea/Hypopnoea Index; 
(events/hour) 
15.1 (6.7) 14.5 (7.4) 0.73 
Oxygen Desaturation 
Index (events/hour) 
14.7 (6.3) 14.6 (7.0) 0.94 
mean blood oxygen 
saturation (%)* 
94.9 (6.2) 94.7 (4.8) 0.97 
Total Sleep Time 
(minutes) 
368 (54) 362 (67) 0.74 
Wake After Sleep Onset 
(minutes)* 
57 (180) 65 (154) 0.65 
Sleep Efficiency (%)* 83.6 (41.8) 80.5 (38.5) 0.38 
Wake of Sleep Period (%)* 13.1 (40.0) 14.6 (35.5) 0.56 
N1 of Sleep Period (%)* 7.0 (20.3) 6.9 (20.5) 0.84 
N2 of Sleep Period (%) 37.1 (7.7) 35.7 (7.8) 0.50 
N3 of Sleep Period (%) 21.5 (7.7) 22.4 (7.1) 0.63 
Rapid Eye Movement 
sleep of Sleep Period (%) 
17.7 (5.4) 16.3 (5.5) 0.37 
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Periodic Limb Movements 
Index* (events/hour) 
0.2 (7.0) 0.0 (7.0) 0.32 
Limb Movements Index* 
(events/hour) 
4.7 (22.8) 3.7 (26.4) 0.39 
Heart Rate (beats/min) 64.7 (7.8) 62.9 (9.0) 0.45 
 
* Non-normally distributed data compared by non-parametric Mann-Witney test. 
 
 
 
 
